Recently, GRM2 downregulation in the substantia nigra has been associated with PD [40] since mGluR2 is essential for the induction of long-term depression (LTD) in the substantia nigra and mGluR2 agonists have been proposed for the treatment of motor symptoms in PD [41,42,43]. Here, GRM2 is linked to Parkinson disease.